These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32203145)

  • 41. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
    Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
    Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
    Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
    Da M; Chen L; Enk A; Ring S; Mahnke K
    Front Immunol; 2022; 13():914799. PubMed ID: 35711418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
    Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
    FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39.
    Neshat S; deVries M; Barajas-Espinosa AR; Skeith L; Chisholm SP; Lomax AE
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G399-405. PubMed ID: 19074640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Watson D; Sluyter R
    Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.
    Ye L; Goodall JC; Zhang L; Putintseva EV; Lam B; Jiang L; Liu W; Yin J; Lin L; Li T; Wu X; Yeo G; Shugay M; Chudakov DM; Gaston H; Xu H
    Immunol Cell Biol; 2016 Mar; 94(3):293-305. PubMed ID: 26467610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
    Kim K; Perera R; Tan DB; Fernandez S; Seddiki N; Waring J; French MA
    Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ENTPD1/CD39 is a promising therapeutic target in oncology.
    Bastid J; Cottalorda-Regairaz A; Alberici G; Bonnefoy N; Eliaou JF; Bensussan A
    Oncogene; 2013 Apr; 32(14):1743-51. PubMed ID: 22751118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas.
    Dzhandzhugazyan KN; Kirkin AF; thor Straten P; Zeuthen J
    FEBS Lett; 1998 Jul; 430(3):227-30. PubMed ID: 9688544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory T cells participate in CD39-mediated protection from renal injury.
    Wang YM; McRae JL; Robson SC; Cowan PJ; Zhang GY; Hu M; Polhill T; Wang Y; Zheng G; Wang Y; Lee VW; Unwin RJ; Harris DC; Dwyer KM; Alexander SI
    Eur J Immunol; 2012 Sep; 42(9):2441-51. PubMed ID: 22684996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
    Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
    Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.
    Boer MC; van Meijgaarden KE; Bastid J; Ottenhoff TH; Joosten SA
    Eur J Immunol; 2013 Jul; 43(7):1925-32. PubMed ID: 23606272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
    Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
    J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
    Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
    J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
    Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
    Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
    J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of the T Cell Response by CD39.
    Takenaka MC; Robson S; Quintana FJ
    Trends Immunol; 2016 Jul; 37(7):427-439. PubMed ID: 27236363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implications of CD39 in immune-related diseases.
    Zeng J; Ning Z; Wang Y; Xiong H
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107055. PubMed ID: 33045579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.